101 – 110 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement
(
- Contribution to journal › Article
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article
-
Mark
Psychological profile related to malignant tumours of different histopathology
(
- Contribution to journal › Article
- 1997
-
Mark
The Swedish Knee Arthroplasty study with special reference to unicompartmental prostheses.
1997)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Hereditary Breast Cancer in South Sweden. Early findings from studies on the role of BRCA1
1997)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations
(
- Contribution to journal › Article
-
Mark
Management of the univentricular connection : are we improving?
(
- Contribution to journal › Article